EUVIMEDEUVIMED entdecken
Randomisierte kontrollierte StudieOpen Access

Home‐based self‐sampling vs clinician sampling for anal precancer screening: The Prevent Anal Cancer Self‐Swab Study

Alan G Nyitray iD, Jenna Nitkowski, Timothy L McAuliffe, Bridgett Brzezinski, Michael D Swartz, María E Fernandez, Ashish A Deshmukh iD, Timothy J Ridolfi, Sarah J Lundeen, Leslie Cockerham, Dave Wenten, Andrew Petroll und 6 weitere

International Journal of Cancer · 2023

DOI: 10.1002/ijc.34553 ↗

Kurz gefasst

Randomisierte kontrollierte Studie in der Zeitschrift International Journal of Cancer, 2023. Verfasst von Alan G Nyitray und 17 weiteren Autor:innen. Beteiligte Einrichtung: Clinical Cancer Center, Medical College of Wisconsin, Milwaukee, Wisconsin, USA. Hauptthemen laut MEDLINE: Papillomavirus Infections, Anus Neoplasms, HIV Infections. Die Arbeit wurde bisher 33-mal zitiert (Crossref) und nennt 34 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NCI NIH HHS, NCATS NIH HHS, Cancer Prevention and Research Institute of Texas.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Sexual minority men are at increased risk for anal squamous cell carcinoma. Our objective was to compare screening engagement among individuals randomized to self‐collect an anal canal specimen at home or to attend a clinic appointment. Specimen adequacy was then assessed for human papillomavirus (HPV) DNA genotyping. A randomized trial recruited cisgendered sexual minority men and transgender people in the community and assigned them to use a home‐based self‐collection swabbing kit or attend a clinic‐based swabbing. Swabs were sent for HPV genotyping. The proportions of participants completing screening in each study arm and the adequacy of their specimens for HPV genotyping were assessed. Relative risks were estimated for factors associated with screening. A total of 240 individuals were randomized. Age (median, 46 years) and HIV status (27.1% living with HIV) did not differ by study arm. A total of 89.2% and 74.2% of home‐arm and clinic‐arm individuals returned the swab, respectively ( P = .003), difference between groups, 15.0% (95% CI 5.4%‐24.6%). Among black individuals, 96.2% and 63.2% in the home and clinic arms screened ( P = .006). Among individuals with HIV, 89.5% and 51.9% in the home and clinic arms screened ( P < .001). Self‐collected swabs and clinician‐collected swabs were comparable in adequacy for HPV genotyping (96.3% and 93.3%, respectively). People at highest risk for anal cancer may be more likely to screen if they are able to self‐collect swabs at home rather than attend a clinic.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Papillomavirus InfectionsAnus NeoplasmsHIV InfectionsMaleHumansMiddle AgedAnal CanalPapillomaviridaeEarly Detection of CancerHomosexuality, Male

Stichwörter der Autor:innen

HIVanal neoplasmshuman papillomavirus DNA testsself-testingsexual and gender minorities

Autor:innen und Institutionen

  • Clinical Cancer Center, Medical College of Wisconsin, Milwaukee, Wisconsin, USA.
  • Center for AIDS Intervention Research, Medical College of Wisconsin, Milwaukee, Wisconsin, USA.
  • Department of Biostatistics and Data Science, The University of Texas Health Sciences Center at Houston School of Public Health, Houston, Texas, USA.
  • Department of Health Promotion and Behavioral Sciences, The University of Texas Health Sciences Center at Houston School of Public Health, Houston, Texas, USA.
  • Department of Public Health Sciences, Medical University of South Carolina, Charleston, South Carolina, USA.
  • Cancer Control Program, Hollings Cancer Center, Medical University of South Carolina, Charleston, South Carolina, USA.

ORCID-Profile: Alan G Nyitray, Ashish A Deshmukh, Jennifer S Smith, Anna R Giuliano

Förderung

  • NCI NIH HHS
  • NCATS NIH HHS
  • Cancer Prevention and Research Institute of Texas
  • Division of Cancer Prevention, National Cancer Institute

Zitieren

APA

Nyitray, A. G., Nitkowski, J., McAuliffe, T. L., Brzezinski, B., Swartz, M. D., Fernandez, M. E., Deshmukh, A. A., Ridolfi, T. J., Lundeen, S. J., Cockerham, L., Wenten, D., Petroll, A., Hilgeman, B., Smith, J. S., Chiao, E. Y., Giuliano, A. R., Schick, V., & Prevent Anal Cancer Self-Swab Study Team (2023). Home‐based self‐sampling vs clinician sampling for anal precancer screening: The Prevent Anal Cancer Self‐Swab Study. International Journal of Cancer. https://doi.org/10.1002/ijc.34553

Vancouver

Nyitray AG, Nitkowski J, McAuliffe TL, Brzezinski B, Swartz MD, Fernandez ME, et al. Home‐based self‐sampling vs clinician sampling for anal precancer screening: The Prevent Anal Cancer Self‐Swab Study. International Journal of Cancer. 2023. doi:10.1002/ijc.34553

BibTeX
@article{Nyitray2023,
  author = {Nyitray, Alan G and Nitkowski, Jenna and McAuliffe, Timothy L and Brzezinski, Bridgett and Swartz, Michael D and Fernandez, María E and Deshmukh, Ashish A and Ridolfi, Timothy J and Lundeen, Sarah J and Cockerham, Leslie and Wenten, Dave and Petroll, Andrew and Hilgeman, Brian and Smith, Jennifer S and Chiao, Elizabeth Y and Giuliano, Anna R and Schick, Vanessa and Prevent Anal Cancer Self-Swab Study Team, Prevent Anal Cancer Self-Swab Study Team},
  title = {Home‐based self‐sampling vs clinician sampling for anal precancer screening: The Prevent Anal Cancer Self‐Swab Study},
  journal = {International Journal of Cancer},
  year = {2023},
  doi = {10.1002/ijc.34553}
}
Kostenlos starten →